Central giant cell granuloma

Overview

WikiDoc Resources for Central giant cell granuloma
Articles
Most recent articles on Central giant cell granuloma Most cited articles on Central giant cell granuloma Review articles on Central giant cell granuloma Articles on Central giant cell granuloma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Central giant cell granuloma Images of Central giant cell granuloma Photos of Central giant cell granuloma Podcasts & MP3s on Central giant cell granuloma Videos on Central giant cell granuloma
Evidence Based Medicine
Cochrane Collaboration on Central giant cell granuloma Bandolier on Central giant cell granuloma TRIP on Central giant cell granuloma
Clinical Trials
Ongoing Trials on Central giant cell granuloma at Clinical Trials.gov Trial results on Central giant cell granuloma Clinical Trials on Central giant cell granuloma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Central giant cell granuloma NICE Guidance on Central giant cell granuloma NHS PRODIGY Guidance FDA on Central giant cell granuloma CDC on Central giant cell granuloma
Books
Books on Central giant cell granuloma
News
Central giant cell granuloma in the news Be alerted to news on Central giant cell granuloma News trends on Central giant cell granuloma
Commentary
Blogs on Central giant cell granuloma
Definitions
Definitions of Central giant cell granuloma
Patient Resources / Community
Patient resources on Central giant cell granuloma Discussion groups on Central giant cell granuloma Patient Handouts on Central giant cell granuloma Directions to Hospitals Treating Central giant cell granuloma Risk calculators and risk factors for Central giant cell granuloma
Healthcare Provider Resources
Symptoms of Central giant cell granuloma Causes & Risk Factors for Central giant cell granuloma Diagnostic studies for Central giant cell granuloma Treatment of Central giant cell granuloma
Continuing Medical Education (CME)
CME Programs on Central giant cell granuloma
International
Central giant cell granuloma en Espanol Central giant cell granuloma en Francais
Business
Central giant cell granuloma in the Marketplace Patents on Central giant cell granuloma
Experimental / Informatics
List of terms related to Central giant cell granuloma

Central giant cell granuloma (CGCG) is a benign condition of the jaws. It is twice as likely to affect women and is more likely to occur 20 - 40 year old people. Central giant cell granulomas are more common in the mandible and often crosses the midline.

CGCG is a benign intraosseous lesion found in the anterior of the maxilla and the mandible in younger people (before age 20). It is characterized by large lesions that expand the cortical plate and can reabsorb roots and move teeth. It is composed of mulitnucleated giant cells. It has a slight predilection for females.

Radiographically it appears as multilocular radiolucencies of bone.

There are two types of CGCG's, Non-aggressive and aggressive. The former has a slow rate of growth and thus less likely to absorb roots and perforate the cortical plate. The aggressive form has rapid growth and thus is much more likely to absorb roots and perforate the cortical plate. It also has a high rate for recurrence and can be painful and cause paresthesia.

Differential diagnosis to include: OKC, ameloblastoma, odontogentic myxoma, hemangioma, central odontogenic fibroma, hyperparathyroid tumor, and cherubism.

Histology

The histology of CGCG is one that is composed of many multinucleated giant cells. There is evidence that these giant cells represent osteoclasts,(bone-eating cells), others suggest more like macrophages. The giant cells may be diffusely located throughout the lesion, or focally aggregate in the lesion. The giant cells are large and round or small and irregular, they vary greatly in size and shape.

Treatment

The treatment for CGCG is thorough curettage. A referral is made to oral surgeon. Reoccurance ranges from 15%-20%. In aggressive tumors, three alternatives to surgery are undergoing investigation. . corticosteroids . calcitonin (salmon calcitonin) . interferon α-2a. These therapeutic approaches provide positive possible alternatives for large lesions. The long term prognosis of giant cell granulomas is good and metastases do not develop.

References

• Kahn, Michael A. Basic Oral and Maxillofacial Pathology. Volume 1. 2001.
• Neville, Brad et al. Oral and Maxillofacial Pathology, second edition. 2002.

Template:WS